Skip to main content

Animations

MJFF Publications

4001 - 4010 of 6451 Results
Title
Year
  • Year
  • 2025
  • 2023
  • 2026
  • 2020
  • 2022
  • 2020
  • 2026
  • 2016
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Free water predicts dementia with Lewy bodies in isolated REM sleep behavior disorder
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.70570
    Citation Count: 2
  • A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studies
    2023
    Summary Details
    OPEN
    Title: A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studies
    Journal Name: Annals of Epidemiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.annepidem.2023.04.019
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Spatial single-cell multiomics reveals peripheral immune dysfunction in Parkinson’s and inflammatory bowel disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-01199-2
    Citation Count: 0
  • Summary Details
    OPEN
    Title: SparkINFERNO: a scalable high-throughput pipeline for inferring molecular mechanisms of non-coding genetic variants
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btaa246
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementia
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51482
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaa020
    Citation Count: 85
  • Summary Details
    OPEN
    Title: Clinical Progression in Alpha‐Synuclein Positive LRRK2 ‐ PD and Sporadic Parkinson's Disease: A Longitudinal Analysis
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.70640
    Citation Count: 0
  • Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression
    2016
    Summary Details
    OPEN
    Title: Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26754
    Citation Count: 149
  • Summary Details
    OPEN
    Title: Shared Genetics of Multiple System Atrophy and Inflammatory Bowel Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28338
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.25944
    Citation Count: 73
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.